Inventor · Cambridge, GB

David John Fox

17Patents
2h-index
4Co-inventors
43Inventor score

Filing activity: Aug 10, 2005 → Jun 13, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7662967B2 Anti-inflammatory compounds and compositions Human Necessities 2 Active
US11312689B2 Compounds and their use for the treatment of alpha1-antitrypsin deficiency Chemistry; Metallurgy 2 Active
US7897620B2 Methods of using anti-inflammatory compounds Human Necessities 2 Active
US7691845B2 Anti-inflammatory agents Human Necessities 1 Expired
US8008289B2 α-aminocyclolactam ligands for G-protein coupled receptors Chemistry; Metallurgy 1 Active
US8008288B2 Anti-inflammatory A-aminocyclolactam compounds Chemistry; Metallurgy 1 Active
US7803794B2 Anti-inflammatory agents Chemistry; Metallurgy 1 Active
US12365672B2 Compounds and their use for the treatment of alpha1-antitrypsin deficiency Chemistry; Metallurgy 0 Active
US12286402B2 Compounds and their use for the treatment of alpha1-antitrypsin deficiency Human Necessities 0 Active
US8618283B2 Ligand libraries for screening GPCRs Chemistry; Metallurgy 0 Active
US8076323B2 Anti-inflammatory agents Chemistry; Metallurgy 0 Active
US12221422B2 Compounds and their use for the treatment of alpha1-antitrypsin deficiency Chemistry; Metallurgy 0 Active
US8497261B2 3-aminocaprolactam compounds for treating inflammatory disorders Human Necessities 0 Active
US12291507B2 Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency Chemistry; Metallurgy 0 Active
US8063106B2 ApoE mimetic agents Human Necessities 0 Active
US8389279B2 α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same Chemistry; Metallurgy 0 Active
US8853200B2 Treatment of rheumatoid arthritis with 3-amino lactam compounds Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.